Application 062876
- Type
- ANDA
- Sponsor
- TARO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NYSTATIN | NYSTATIN | SUSPENSION;ORAL | 100,000 UNITS/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50090-2937 | Nystatin | Nystatin | A-S Medication Solutions | ANDA | Current |
| 51672-4117 | Nystatin | Nystatin | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-4117 | Nystatin | Nystatin | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 70166-331 | Nystatin | Nystatin | Lohxa | ANDA | Current |